These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6150183)

  • 21. Captopril in heart failure. A double blind controlled trial.
    Cleland JG; Dargie HJ; Hodsman GP; Ball SG; Robertson JI; Morton JJ; East BW; Robertson I; Murray GD; Gillen G
    Br Heart J; 1984 Nov; 52(5):530-5. PubMed ID: 6388612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
    Maslowski AH; Ikram H; Nicholls MG; Espiner EA
    Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.
    Sharpe DN; Douglas JE; Coxon RJ; Long B
    Lancet; 1980 Nov; 2(8205):1154-7. PubMed ID: 6107767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
    Dahlström U; Karlberg BE
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of captopril on the exercise performance in patients with congestive heart failure].
    Han YL; Tong M; Miao ZL
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):281-3, 317. PubMed ID: 1478125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment.
    Rajagopalan B; Raine AE; Cooper R; Ledingham JG
    Am J Med; 1984 May; 76(5B):86-90. PubMed ID: 6328990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment.
    Massie BM
    Am J Med; 1988 Mar; 84(3A):75-82. PubMed ID: 3064602
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
    Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P
    Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibition in heart failure.
    Cleland JG; Dargie HJ; Robertson JI
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):157S-160S. PubMed ID: 6099732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril in congestive heart failure.
    Liebau G; Riegger AJ; Schanzenbächer P; Steilner H; Oehrlein S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):193S-199S. PubMed ID: 6753901
    [No Abstract]   [Full Text] [Related]  

  • 33. Captopril in patients with terminal cardiac failure.
    Nicholls MG; Ikram H; Hull FT
    N Z Med J; 1982 Oct; 95(718):736-8. PubMed ID: 6755319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 36. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):45-50. PubMed ID: 2450255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of captopril on renal function in patients with congestive heart failure.
    Pierpont GL; Francis GS; Cohn JN
    Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute and long-term effect of captopril in severe chronic heart failure].
    Kikis D; Heck I; Stumpe KO; Esser H
    Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.